by Alan Jernigan | Oct 5, 2018 | Abstract Preview
Similar to our previous blog posts covering the AABB abstracts from Vancouver General Hospital, The University of Colorado Hospital, and Vienna General Hospital this post covers an abstract generated by a hospital that recently evaluated ThromboLUX. This time we are... by Alan Jernigan | Sep 28, 2018 | Abstract Preview
Similar to our previous blog posts covering the AABB abstracts from Vancouver General Hospital and The University of Colorado Hospital, this post presents an abstract generated by a hospital that recently completed a study using ThromboLUX. This time we are looking at... by Alan Jernigan | Sep 20, 2018 | Abstract Preview
Similar to the previous blog post covering the AABB abstracts from the Vancouver General Hospital study, this post will cover an abstract generated by a hospital that has recently evaluated ThromboLUX. This time we are looking at the work done by Dr. Inga Gurrevich,... by Alan Jernigan | Sep 13, 2018 | Abstract Preview
Over the next four weeks, this blog will be previewing upcoming AABB 2018 abstracts that feature ThromboLUX. This post covers two abstracts that came out of one study. The data set generated during a randomized controlled trial conducted at Vancouver General Hospital... by Alan Jernigan | May 3, 2018 | Abstract Preview, Data Summary
A registered clinical study investigating the effect of platelet activation status on transfusion outcomes was conducted at Vancouver General Hospital (VGH) from 2011 to 2014 under the guidance of Dr. Kate Chipperfield. This study enrolled 200 hematology-oncology... 